March 15, 2025

DKK

Home DKK
Finance

Coloplast A/S – Interim Financial Report, 9M 2023/24

  • August 20, 2024

Coloplast A/S 9M 2023/24Interim financial results, 9M 2023/241 October 2023 – 30 June 2024 Coloplast delivered 8% organic growth and an EBIT margin1) of 27% in Q3, with 11% growth in absolute EBIT1). Reported revenue in DKK grew 13% which includes 4%-points contribution from Kerecis (underlying growth of around 35%). Organic growth rates by business

Read More
Finance

DSV, 1123 – INTERIM FINANCIAL REPORT H1 2024

  • July 24, 2024

DSV A/S Company Announcement No. 1123 Strong Q2 2024 results with market share gains in all divisions The DSV Group achieved strong Q2 2024 results in line with expectations, with a decline in gross profit of 4.0% and a 12.4% decline in EBIT before special items compared to the same period last year. The financial

Read More
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent. View more
Accept
Decline